Add Row
Add Element
Glytain Logo
update
Glytain.com
update
Add Element
  • Home
  • Categories
    • Healthcare
    • Innovation
    • Digital
    • Marketing
    • Analysis
    • Insights
    • Trends
    • Empowerment
    • Providers
    • Tech News
    • Extra News
September 10.2025
2 Minutes Read

Why A Third of Employers Can't Access Medical Claims Data and What It Means

Businessman analyzing data for access to medical claims information.

Navigating the Data Dilemma: Why Medical Claims Access Matters

A recent survey conducted by the National Alliance of Healthcare Purchaser Coalitions highlights a pressing issue in the healthcare landscape: one-third of employers are struggling to access their medical claims data from health vendors, including pharmacy benefit managers (PBMs) and insurers. This lack of access is more than just a minor inconvenience; it poses a significant barrier to employers’ abilities to manage healthcare costs effectively.

The Implications of Limited Data Access on Healthcare Costs

Employers who can access their claims data are in a better position to implement proactive cost-control strategies, such as conducting audits of their PBM contracts and leveraging innovative payment models like direct contracting with providers. The ability to analyze healthcare utilization patterns allows employers to make informed decisions, improve healthcare outcomes, and combat soaring costs. In fact, survey results revealed that 99% of employers believe that high drug prices, rising hospital fees, and costly claims are the most significant threats to their affordability.

Who Struggles the Most? Size Matters

Interestingly, data access largely correlates with company size. The survey found that 74% of employers with more than 50,000 employees reported having full access to their claims data, compared to only 52% of those with fewer than 1,000 employees. This disparity raises concerns about equity and highlights a systemic issue where larger employers can leverage their resources to negotiate better terms with vendors.

Changing Landscapes: The Shift Towards Transparency

The survey also underscored a notable trend: many employers are reconsidering their partnerships with the industry’s top three PBMs—CVS Caremark, Express Scripts, and Optum Rx—opting instead for transparent vendors. This shift is partly driven by dissatisfaction with hospital consolidations, as 60% of employers expressed skepticism about their impact on cost and quality. Such sentiments reflect a broader demand for transparency and accountability in the healthcare sector.

Conclusion: A Call for Action

As employers navigate these challenges, it’s clear that access to medical claims data is not just a technical requirement; it’s a strategic necessity. Employers must advocate for reforms leading to increased data access and transparency, ensuring they can manage healthcare costs effectively while improving the quality of care for their employees. The current state of healthcare demands proactive solutions, as echoed by National Alliance’s president, Shawn Gremminger, who aptly termed the situation a “dumpster fire” for those unwilling to challenge the status quo. Employers should band together to push for policy changes that enhance data accessibility and promote fair pricing within healthcare.

Healthcare

Write A Comment

*
*
Related Posts All Posts

New Atrial Fibrillation Management Guidelines: Why Early Intervention is Key

Update Understanding Atrial Fibrillation: The Latest Guidelines Explained In the realm of cardiac health, atrial fibrillation (AFib) continues to be a prominent concern for healthcare providers and patients alike. Recent updates in AFib management guidelines have shed light on new strategies aimed at improving patient outcomes. These changes underscore a shift towards early intervention and a better understanding of the disease's progressive nature.In Recent Updates in AF Guidelines, the discussion dives into the key changes in AFib management, prompting a deeper analysis of their implications. Early Intervention: Why It Matters A significant highlight of the revised guidelines is the emphasis on early rhythm control strategies. Studies suggest that managing AFib early can help reduce symptoms and the likelihood of progression to more persistent forms of the condition. As Dr. DeSimone noted, viewing AFib as a continuous disease rather than a series of acute episodes means that proactive management is key. The message is clear: addressing AFib sooner can lead to better long-term health outcomes. Innovative Approaches: The Role of Catheter Ablation The guidelines have also recommended a more aggressive use of catheter ablation for symptomatic patients. This minimally invasive procedure aims to restore a normal heart rhythm. The inclusion of catheter ablation as a primary option for patients with paroxysmal AFib marks a shift in treatment philosophy, promoting a faster resolution for those suffering from this condition. Understanding AFib in Heart Failure Patients For patients with heart failure, the relationship between AFib and reduced heart function presents unique challenges. The guidelines highlight that treating AFib can be critical in recovering cardiac function, potentially reversing heart failure symptoms. It’s essential for healthcare providers to not only manage AFib but to look for ways to restore heart function, especially when it has been compromised by AFib. The Importance of Individualized Care One of the most encouraging aspects of the new guidelines is the recognition of the need for individualized care. Each patient’s experience with AFib is different, and treatment should be tailored to fit their specific needs, symptoms, and lifestyle. Healthcare providers are encouraged to engage in shared decision-making, ensuring that patients are part of the conversation about their treatment options. The latest guidelines on atrial fibrillation management illustrate a progressive and patient-centered approach to treatment. By embracing early intervention and recognizing the importance of tailored care, healthcare providers can better support those living with AFib. For anyone affected by heart health issues, staying informed about these guidelines can be empowering and beneficial to their overall well-being.

Strengthening Healthcare Resilience: A Critical Test for Cybersecurity

Update Healthcare Cybersecurity Challenges: An Increasing Threat In today’s digital age, healthcare organizations face an unprecedented onslaught of cyber threats that threaten the integrity of patient care and financial stability. Recent findings indicate that over half of the IT leaders across various sectors report experiencing a data breach, with costs exceeding $1 million. For healthcare providers, such incidents can severely disrupt service delivery, as seen in a small Illinois hospital that closed its doors due to lingering effects of a ransomware attack. The Critical Link Between Cybersecurity and Patient Care In the face of these challenges, healthcare providers are recognizing that a robust cybersecurity strategy is crucial not only for protection but also for the fundamental mission of delivering care. Cybersecurity breaches can prevent providers from fulfilling their critical functions — from telemedicine consultations to emergency services — potentially endangering lives in the process. Building Resilience through Teamwork and Training Fortunately, there are silver linings in the cloud of cybersecurity threats. Leaders in the healthcare sector are beginning to share insights from their experiences and focus on building cyber-resilient infrastructures. For instance, CISO Sanjeev Sah of Novant Health emphasizes cultivating an inclusive workplace culture that fosters continuous professional growth, thereby reinforcing the human element of cybersecurity. Enhanced training programs aimed at combatting phishing and social engineering attacks are essential moves toward strengthening the workforce’s defenses against these threats. Preparing for Future Threats: An Ongoing Journey The ongoing effort to balance cybersecurity and healthcare delivery reminds all stakeholders that preparation is key. For organizations to truly thrive in this digital landscape, they must evolve their strategies and invest in both human resources and technology. This proactive approach can help healthcare systems not only recover from attacks but ultimately prevent them, safeguarding patient care and trust.

Monarez's Senate Testimony: What It Means for Vaccine Policy and Public Trust

Update Anticipation Grows as Monarez Prepares to TestifySusan Monarez, the former director of the Centers for Disease Control and Prevention (CDC), is scheduled to testify before the Senate next week, marking a pivotal moment in the ongoing discourse about vaccine policies and health agency integrity. Having been ousted after just one month in her position, Monarez's testimony is expected to shed light on the controversial changes implemented by Health Secretary Robert F. Kennedy Jr., stirring speculation about the future direction of public health governance.Context of the Testimony: The Landscape Changes at the CDCThis hearing set for September 17, coinciding with a meeting of the CDC’s vaccine advisory committee, is critical. It comes at a time when vaccine hesitancy and public trust in health agencies are precarious. Monarez, who resisted Kennedy's radical policies, may reveal insights that could either reinforce or challenge perceptions of the agency's credibility.Implications for Public Health and Vaccine PolicyLeading the Senate health panel, Senator Bill Cassidy (R-La.) has been vocal about his concerns over Kennedy’s approach, which he argues can jeopardize the health of American children. The political tug-of-war, intensified by Kennedy's contradictory statements regarding Monarez's departure and the reshaping of CDC’s priorities, highlights deep fractures in public health policy that could have long-term consequences.The Importance of Transparency in Health GovernanceAs public speakers stress the need for 'radical transparency,' it becomes clear that how federal health agencies operate post-testimony will be pivotal for restoring trust. Senators and health officials alike will need to navigate these complex dynamics to ensure that the health of American citizens is not compromised.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*